+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Toxicology Drug Screening Market by Product (Animal Models, Instruments, Reagents & Consumables), Testing (In Silico, In Vitro, In Vivo), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 199 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5675244
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Toxicology Drug Screening Market size was estimated at USD 27.07 billion in 2023, USD 30.59 billion in 2024, and is expected to grow at a CAGR of 13.38% to reach USD 65.22 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Toxicology Drug Screening Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Toxicology Drug Screening Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Toxicology Drug Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International, Inc., Clinical Reference Laboratory, Inc., Enzo Life Sciences, Inc., Eurofins Scientific SE, GE Healthcare, Laboratory Corporation of America Holdings, Promega Corporation, Quest Diagnostics, Selvita S.A., Thermo Fisher Scientific Inc., Waters Corporation, and Wuxi AppTec Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Toxicology Drug Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Animal Models
    • Instruments
    • Reagents & Consumables
    • Software
  • Testing
    • In Silico
    • In Vitro
    • In Vivo
  • Application
    • Developmental & Reproductive Toxicity
    • Endocrine Disruption
    • Immunotoxicity
    • Systemictoxicity
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Toxicology Drug Screening Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Toxicology Drug Screening Market?
  3. What are the technology trends and regulatory frameworks in the Toxicology Drug Screening Market?
  4. What is the market share of the leading vendors in the Toxicology Drug Screening Market?
  5. Which modes and strategic moves are suitable for entering the Toxicology Drug Screening Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Toxicology Drug Screening Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing practice of workplace drug testing and high penetration of point of care testing (POCT) devices
5.1.1.2. Growing availability of high-end drug screening instruments, reagent and kits
5.1.1.3. Rising government expenditure on toxicity testing
5.1.2. Restraints
5.1.2.1. High Cost of toxicology drug screening tests
5.1.3. Opportunities
5.1.3.1. Introduction of advanced toxicology drug screening tests
5.1.3.2. Rise in adoption of toxicology drug screening in the food and beverage industry, and chemical industry
5.1.4. Challenges
5.1.4.1. Longer time for sample testing associated with toxicology drug screening
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Toxicology Drug Screening Market, by Product
6.1. Introduction
6.2. Animal Models
6.3. Instruments
6.4. Reagents & Consumables
6.5. Software
7. Toxicology Drug Screening Market, by Testing
7.1. Introduction
7.2. In Silico
7.3. In Vitro
7.4. In Vivo
8. Toxicology Drug Screening Market, by Application
8.1. Introduction
8.2. Developmental & Reproductive Toxicity
8.3. Endocrine Disruption
8.4. Immunotoxicity
8.5. Systemictoxicity
9. Americas Toxicology Drug Screening Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Toxicology Drug Screening Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Toxicology Drug Screening Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Agilent Technologies, Inc.
13.1.3. Bio-Rad Laboratories Inc.
13.1.4. Charles River Laboratories International, Inc.
13.1.5. Clinical Reference Laboratory, Inc.
13.1.6. Enzo Life Sciences, Inc.
13.1.7. Eurofins Scientific SE
13.1.8. GE Healthcare
13.1.9. Laboratory Corporation of America Holdings
13.1.10. Promega Corporation
13.1.11. Quest Diagnostics
13.1.12. Selvita S.A.
13.1.13. Thermo Fisher Scientific Inc.
13.1.14. Waters Corporation
13.1.15. Wuxi AppTec Co., Ltd.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. TOXICOLOGY DRUG SCREENING MARKET RESEARCH PROCESS
FIGURE 2. TOXICOLOGY DRUG SCREENING MARKET SIZE, 2022 VS 2030
FIGURE 3. TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. TOXICOLOGY DRUG SCREENING MARKET DYNAMICS
FIGURE 7. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2022 VS 2030 (%)
FIGURE 10. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 12. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. TOXICOLOGY DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. TOXICOLOGY DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. TOXICOLOGY DRUG SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ANIMAL MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 11. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IN SILICO, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IN VITRO, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IN VIVO, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DEVELOPMENTAL & REPRODUCTIVE TOXICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ENDOCRINE DISRUPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IMMUNOTOXICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SYSTEMICTOXICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 31. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 34. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 48. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. INDIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 51. INDIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. JAPAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 57. JAPAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. THAILAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 75. THAILAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 85. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 88. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 91. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 94. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 97. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 103. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 112. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 115. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 118. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 130. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 139. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. TOXICOLOGY DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 147. TOXICOLOGY DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 148. TOXICOLOGY DRUG SCREENING MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc.
  • Charles River Laboratories International, Inc.
  • Clinical Reference Laboratory, Inc.
  • Enzo Life Sciences, Inc.
  • Eurofins Scientific SE
  • GE Healthcare
  • Laboratory Corporation of America Holdings
  • Promega Corporation
  • Quest Diagnostics
  • Selvita S.A.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • Wuxi AppTec Co., Ltd.

Methodology

Loading
LOADING...

Table Information